Immune Modulation by Exosomes in COVID-19

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

December 22, 2021

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2026

Conditions
COVID-19Critical IllnessHypercytokinemiaLung Fibrosis
Interventions
BIOLOGICAL

Application of exosomes in a whole blood assay

Co-incubation of patient-derived whole blood samples with mesenchymal stem cell derived exosomes and read-out of biomarkers, RNA and immune phenotypes after 24h.

Trial Locations (1)

89070

RECRUITING

Ulm University Hospital, Clinic of Anesthesiology and Intensive Care Medicine, Ulm

All Listed Sponsors
lead

University of Ulm

OTHER